In an exciting development, Rasayan Labs has unveiled a groundbreaking AI-based platform to enhance computational chemistry and drug discovery initiatives. This innovative platform merges critical functions, including retrosynthesis and ADMET prediction, to optimize research efficiency. Free access will be granted to researchers at the Institute of Chemical Technology, marking a pivotal collaboration that seeks to dramatically reduce drug development timelines.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.